Etofibrate
CAS : 31637-97-5
Ref. 3D-FE23196
25mg | À demander | ||
50mg | À demander | ||
100mg | À demander | ||
250mg | À demander | ||
500mg | À demander |
Informations sur le produit
- 3-Pyridinecarboxylic acid 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]ethyl esterEthofibrateLipo-merz
- 2-{[2-(4-Chlorophenoxy)-2-Methylpropanoyl]Oxy}Ethyl Pyridine-3-Carboxylate
- 2-{[2-(4-Chlorophenoxy)-2-methylpropanoyl]oxy}ethyl nicotinate
- 250-743-1
- 3-Pyridinecarboxylic Acid, 2-[2-(4-Chlorophenoxy)-2-Methyl-1-Oxopropoxy]Ethyl Ester
- Ethofibrate
- Ethylene Glycol 1-[2-(p-Chlorophenoxy)-2-methylpropionate]-2-nicotinate
- Lipo-Merz
- Nicotinic Acid 2-Hydroxyethyl Ester 2-(p-Chlorophenoxy)-2-methylpropionate (Ester)
- Tricerol
- Voir d'autres synonymes
- a-[(p-Chlorophenoxy)isobutyroyl]-b-(nicotinoyl)glycol
Etofibrate is a pyrazole-containing compound that inhibits the enzyme DPP-IV, which is involved in the degradation of glucagon, thereby increasing the level of circulating glucagon. Etofibrate has been shown to be useful for treating people with bowel disease and hypoglycemic effect. It has also been shown to have anti-inflammatory effects. The mechanism of action is not well understood, but it may be due to its ability to inhibit lipid synthesis or decrease cholesterol levels. Etofibrate can be used as a cholesterol-lowering agent in patients with type 2 diabetes and atherosclerosis. It also has an immunomodulatory effect on infectious diseases such as tuberculosis by inhibiting the growth of bacteria and reducing inflammation.
Propriétés chimiques
Question d’ordre technique sur : 3D-FE23196 Etofibrate
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages